Association between herpes simplex virus infection and Alzheimer’s disease biomarkers: analysis within the MAPT trial

Abstract In vitro and animal studies have suggested that inoculation with herpes simplex virus 1 (HSV-1) can lead to amyloid deposits, hyperphosphorylation of tau, and/or neuronal loss. Here, we studied the association between HSV-1 and Alzheimer’s disease biomarkers in humans. Our sample included 1...

Full description

Saved in:
Bibliographic Details
Main Authors: Morgane Linard, Isabelle Garrigue, Bruno Vellas, Nicola Coley, Henrik Zetterberg, Kaj Blennow, Nicholas James Ashton, Pierre Payoux, Anne-Sophie Salabert, Jean-François Dartigues, Joachim Mazere, Sandrine Andrieu, Catherine Helmer
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-84583-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594746104610816
author Morgane Linard
Isabelle Garrigue
Bruno Vellas
Nicola Coley
Henrik Zetterberg
Kaj Blennow
Nicholas James Ashton
Pierre Payoux
Anne-Sophie Salabert
Jean-François Dartigues
Joachim Mazere
Sandrine Andrieu
Catherine Helmer
author_facet Morgane Linard
Isabelle Garrigue
Bruno Vellas
Nicola Coley
Henrik Zetterberg
Kaj Blennow
Nicholas James Ashton
Pierre Payoux
Anne-Sophie Salabert
Jean-François Dartigues
Joachim Mazere
Sandrine Andrieu
Catherine Helmer
author_sort Morgane Linard
collection DOAJ
description Abstract In vitro and animal studies have suggested that inoculation with herpes simplex virus 1 (HSV-1) can lead to amyloid deposits, hyperphosphorylation of tau, and/or neuronal loss. Here, we studied the association between HSV-1 and Alzheimer’s disease biomarkers in humans. Our sample included 182 participants at risk of cognitive decline from the Multidomain Alzheimer Preventive Trial who had HSV-1 plasma serology and an amyloid PET scan. Plasma Aβ42/40 ratio, neurofilament light chain and p-tau181 were also available for a sub-sample of participants. Multivariate linear regressions were performed and stratified by APOE4 genotype. The median age was 74.0 years, 85.2% were infected with HSV-1. Infected participants tended to have a lower cortical amyloid load than uninfected participants (β = -0.08, p = 0.06), especially those suspected of reactivating HSV-1 most frequently (i.e. with a high anti-HSV-1 IgG level; n = 58, β = -0.09 p = 0.04). After stratification, the association was only significant in APOE4 carriers (n = 43, β = -0.21 p = 0.01). No association was found with the plasma biomarkers. The trend toward lower cortical amyloid load in HSV-1-infected participants was unexpected given the pre-existing literature and may be explained either by a modified immune response in HSV-1 infected subjects which could favour the clearance of amyloid deposits or by a selection bias.
format Article
id doaj-art-260cbbe1d526489bb4ed348f96fa03ad
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-260cbbe1d526489bb4ed348f96fa03ad2025-01-19T12:21:20ZengNature PortfolioScientific Reports2045-23222025-01-0115111010.1038/s41598-024-84583-xAssociation between herpes simplex virus infection and Alzheimer’s disease biomarkers: analysis within the MAPT trialMorgane Linard0Isabelle Garrigue1Bruno Vellas2Nicola Coley3Henrik Zetterberg4Kaj Blennow5Nicholas James Ashton6Pierre Payoux7Anne-Sophie Salabert8Jean-François Dartigues9Joachim Mazere10Sandrine Andrieu11Catherine Helmer12INSERM U1219 Bordeaux Population Health Research Center, University of BordeauxCNRS, MFP, UMR 5234, University of BordeauxGérontopôle de Toulouse, Institut du Vieillissement, University Hospital of ToulouseINSERM, CERPOP, U1295, University of ToulouseDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of GothenburgDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of GothenburgDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of GothenburgNuclear Medicine Department, University Hospital of ToulouseINSERM ToNIC, U1214, University of ToulouseINSERM U1219 Bordeaux Population Health Research Center, University of BordeauxNuclear Medicine Department, University Hospital of BordeauxINSERM, CERPOP, U1295, University of ToulouseINSERM, Bergonié Institute, BPH, U1219, CIC-P 1401, University of BordeauxAbstract In vitro and animal studies have suggested that inoculation with herpes simplex virus 1 (HSV-1) can lead to amyloid deposits, hyperphosphorylation of tau, and/or neuronal loss. Here, we studied the association between HSV-1 and Alzheimer’s disease biomarkers in humans. Our sample included 182 participants at risk of cognitive decline from the Multidomain Alzheimer Preventive Trial who had HSV-1 plasma serology and an amyloid PET scan. Plasma Aβ42/40 ratio, neurofilament light chain and p-tau181 were also available for a sub-sample of participants. Multivariate linear regressions were performed and stratified by APOE4 genotype. The median age was 74.0 years, 85.2% were infected with HSV-1. Infected participants tended to have a lower cortical amyloid load than uninfected participants (β = -0.08, p = 0.06), especially those suspected of reactivating HSV-1 most frequently (i.e. with a high anti-HSV-1 IgG level; n = 58, β = -0.09 p = 0.04). After stratification, the association was only significant in APOE4 carriers (n = 43, β = -0.21 p = 0.01). No association was found with the plasma biomarkers. The trend toward lower cortical amyloid load in HSV-1-infected participants was unexpected given the pre-existing literature and may be explained either by a modified immune response in HSV-1 infected subjects which could favour the clearance of amyloid deposits or by a selection bias.https://doi.org/10.1038/s41598-024-84583-x
spellingShingle Morgane Linard
Isabelle Garrigue
Bruno Vellas
Nicola Coley
Henrik Zetterberg
Kaj Blennow
Nicholas James Ashton
Pierre Payoux
Anne-Sophie Salabert
Jean-François Dartigues
Joachim Mazere
Sandrine Andrieu
Catherine Helmer
Association between herpes simplex virus infection and Alzheimer’s disease biomarkers: analysis within the MAPT trial
Scientific Reports
title Association between herpes simplex virus infection and Alzheimer’s disease biomarkers: analysis within the MAPT trial
title_full Association between herpes simplex virus infection and Alzheimer’s disease biomarkers: analysis within the MAPT trial
title_fullStr Association between herpes simplex virus infection and Alzheimer’s disease biomarkers: analysis within the MAPT trial
title_full_unstemmed Association between herpes simplex virus infection and Alzheimer’s disease biomarkers: analysis within the MAPT trial
title_short Association between herpes simplex virus infection and Alzheimer’s disease biomarkers: analysis within the MAPT trial
title_sort association between herpes simplex virus infection and alzheimer s disease biomarkers analysis within the mapt trial
url https://doi.org/10.1038/s41598-024-84583-x
work_keys_str_mv AT morganelinard associationbetweenherpessimplexvirusinfectionandalzheimersdiseasebiomarkersanalysiswithinthemapttrial
AT isabellegarrigue associationbetweenherpessimplexvirusinfectionandalzheimersdiseasebiomarkersanalysiswithinthemapttrial
AT brunovellas associationbetweenherpessimplexvirusinfectionandalzheimersdiseasebiomarkersanalysiswithinthemapttrial
AT nicolacoley associationbetweenherpessimplexvirusinfectionandalzheimersdiseasebiomarkersanalysiswithinthemapttrial
AT henrikzetterberg associationbetweenherpessimplexvirusinfectionandalzheimersdiseasebiomarkersanalysiswithinthemapttrial
AT kajblennow associationbetweenherpessimplexvirusinfectionandalzheimersdiseasebiomarkersanalysiswithinthemapttrial
AT nicholasjamesashton associationbetweenherpessimplexvirusinfectionandalzheimersdiseasebiomarkersanalysiswithinthemapttrial
AT pierrepayoux associationbetweenherpessimplexvirusinfectionandalzheimersdiseasebiomarkersanalysiswithinthemapttrial
AT annesophiesalabert associationbetweenherpessimplexvirusinfectionandalzheimersdiseasebiomarkersanalysiswithinthemapttrial
AT jeanfrancoisdartigues associationbetweenherpessimplexvirusinfectionandalzheimersdiseasebiomarkersanalysiswithinthemapttrial
AT joachimmazere associationbetweenherpessimplexvirusinfectionandalzheimersdiseasebiomarkersanalysiswithinthemapttrial
AT sandrineandrieu associationbetweenherpessimplexvirusinfectionandalzheimersdiseasebiomarkersanalysiswithinthemapttrial
AT catherinehelmer associationbetweenherpessimplexvirusinfectionandalzheimersdiseasebiomarkersanalysiswithinthemapttrial